where collagen IV-positive basement membrane were absent exceeded those in areas where it was present (factor of 1.7) and those in normal mucosa (factor of 1.6). The differences in vessel density between individual tumours and the low variability in vessel density within individual tumours using this quantification technique allow us to investigate the prognostic value of vessel density in areas of intense neovascularisation in human primary colorectal carcinomas.
It has been shown that both for tumour growth (Folkman. 1990 ) and for haematogenous spread of tumour cells (Liotta et al., 1974) , the development of blood vessels towards and into the tumour is required. This is achieved by a multistep process referred to as tumour angiogenesis. Microvessel density of a tumour, determined on histological sections is a quantitative measure of this process and has predictive value for the occurrence of metastases in different tumour types (Macchiarini et al., 1992; Wakui et al., 1992) . In patients with breast cancer, the extent of neovascularisation has been shown to be an independent prognostic factor (Weidner et al., 1991; Horak et al., 1992; Toi et al., 1993) . In these studies microvessels were visualised by immunostaining endothelial cells for factor VIII-related antigen and for CD3 1. A monoclonal antibody against CD31 or PECAM (platelet-endothelial cell adhesion molecule) has been shown to identify more vessels in tumour tissue than do antibodies against factor VIII-related antigen (Horak et al., 1992; Toi et al., 1993) . Tumours were also observed to be heterogeneous in their microvessel density. Angiogenesis was always scored after counting microvessels in those tumour areas with the most active neovascularisation.
Colorectal cancer is one of the most prevalent solid tumours. Many clinical, biological and histological variables have been investigated in order to understand colorectal tumour biology and to be able to select high-risk patients for adjuvant therapy. Nevertheless, Dukes' or TNM staging continues to be the most important prognostic factor in colorectal cancer. Adjuvant chemotherapy with fluorouracil plus levamisole reduces tumour recurrence and death rates in patients with Dukes C carcinoma (Moertel et al., 1990 
Materls and methods
A representative, full cross-section tumour sample. surrounded by normal mucosa, was taken from 34 colorectal cancer specimens. The largest diameter of the unfixed tumours was assessed. Specimens were fixed in neutral formalin solution and processed for paraffin sections. Parallel tumour specimens were taken and immediately frozen in liquid nitrogen and stored at -80°C until analysis. For routine histology, haematoxylin and eosin (HE)-stained sections were used. Five micron sections were cut, mounted on poly-L-lysine-coated slides and dewaxed. Endogenous peroxidase activity was quenched by exposing the slides for 30 min to a hydrogen peroxide-in-methanol solution. Sections were pretreated with protease type XXIV (Sigma) in TBS (Tnrsbuffered saline) for 10 min at 37°C. Blood vessels were visualised by staining endothelial cells for CD31 (monoclonal antibody JC70, Dako) (Parums et al., 1990) The staining of vessels by two antibodies, JC70 and factor VIII-related antigen antibody. was compared in 21 cases. Vascular density in tumour sections stained for factor VIIIrelated antigen was assessed using the same method as for JC70-stained vessels and without the knowledge of the counting results using JC70.
Areas of tumour with or without collagen IV-positive basement membrane and of normal mucosa were assessed for vessel density. Adjacent tumour sections were stained with JC70 using the same method. Every area was systematically scanned at x 100 magnification. Instead of counting individual microvessels at x 250 magnification, a high-power magnification of x 400 (0.17 mm2) was applied. The The staining of some inflammatory cells by JC70 did not impair vascular counting. Despite the differences in endothelial cell staining sensitivity and specificity between factor VIII-related antigen staining and CD31 staining, a significant correlation was shown by rank correlation test between both counts (n=21; r=0.81; P<0.01) (Figure 3) .
The number of vascular hotspots encountered in one tumour section ranged from 2 to 7, partly depending on the size of the section. The highest readings with the x 250 magnification within one tumour section were similar. In all tumour sections, microvessel counts of vascular hotspots with the highest vessel density correlated significantly with microvessel counts of vascular hotspots with second highest vessel density (r = 0.95; P<0.01) (Figure 4 Vessel density in colorectal tumour tissue in our study appears to be much higher than in the study performed by Mlynek et al. (1985) : 185 vessels mm ' compared with 23 vessels mnmn. This difference can be partly explained by the vessel markers used in these studies and the different counting methodology. In our study. the entire tumour-section was carefully scanned at low-power magnification in order to find vascular hotspots. Vessel density was assessed in one x 250 field within this highly vascular area. This excludes areas with low vessel density from the counts. resulting in a higher mean vessel density. In the studies by Mlynek et al. (1985) and Porschen et al. (1989) vessel density in normal mucosa was shown to exceed vessel density in tumour tissue by a factor of 2.3 and 1.6 respectively. The opposite was noted in our study: vessel density was shown to be 1.6 times higher in the parts of the tumour lacking basement membrane compared with normal mucosa and submucosa. Again. this probably reflects differences in counting methodology. Both authors have reported a heterogeneity of vascular supply in colorectal tumour tissue, with greater coefficients of variance of vessel density in tumour tissue as compared with normal. Within tumour tissue, areas completely devoid of microvessels can easily be found. whereas normal colorectal tissue shows evenly distributed vessels.
We decided to determine microvessel density only in the areas of the most intensive neovascularisation because this method has recently proven to have prognostic value in invasive breast carcinoma (Horak et al.. 1992; Weidner et al., 1992; Toi et al., 1993) . Indeed, one can speculate that the onset of intense angiogenic activity within a tumour might be restricted to a few areas within a tumour. The occasional observation of a colorectal tumour with a uniformly low vessel density could support this hypothesis. We never encountered tumours with a uniformly high vessel density. Our results on vessel density in colorectal carcinomas can be compared with those observed in breast carcinomas using an identical counting method. Weidner et al. (1992) and endothelial cell adhesion molecule and appears to be the only available formalin-resistant endothelial cell antigen besides factor VIII-related antigen and CD34. In our experience, the cross-reaction of CD31 with certain inflammatory cells, such as plasma cells or stromal cells, did not prevent accurate microvessel identification. This cross-reactivity could easily be discriminated from true endothelial cell reactivity on the basis of the staining pattern and cell morphology. Toi et al. (1993) reported a difference in cell staining sensitivity between factor VIII-related antigen staining and CD31 staining in primary breast carcinomas. The average vessel count for CD31 was 1.2 times higher than for factor VIII-related antigen. A significant correlation between the two staining methods was shown (P<O.O1). In colorectal carcinomas, vessel counts for CD31 exceeded those for factor VIII-related antigen by a factor of 1.6. A strong correlation between both vessel counts was also observed in our study (P<O.O1). Within one colorectal tumour section, vessel counts in different vascular hotspots, separated by tumour tissue with lower vessel density, were shown to be very similar. These tissue sections were cut out of the tumours in a random way. This suggests that vessel density is a stable parameter throughout the entire colorectal tumour and might point to a biological characteristic of a tumour. This finding is important if quantification of angiogenesis is to become relevant as a prognostic factor in colorectal carcinoma.
